That is incorrect. MIMO relies on multipath to be able to effectively process spatially multiplexed data streams. Think about it - if the signals from independent streams all arrived simultaneously, they would cancel each other. Man, this is basic, basic stuff.

That was true 5 years ago, but MIMO antennas actually benefit from multipath.

You've attended enough schools in enough of the US, UK, and Europe to be able to make that claim? No, of course you haven't, coward. Sit down and shut up.
The rest of your post reads like a wannabe's Hollywood script.

Step 1: Get cancer Step 2: Get measels Step 3: Get rabies Step 4: ??? Step 5: Profit!

It will be addressed in the briefs.

It's ok, we can remember it for you.

Holy shit, 10% of your income, for health insurance? Madness.

This is what happens when you have no governing body - the corporations govern. Ever since Jon Postel died, there has not been a strong leader with no commercial affiliations, which is what the IETF needs - paid (well-paid) positions for scientists who are committed to the advancement of internetworking as a whole. But what happens when something like Cisco's FabricPath beats TRILL to market? You can't regulate innovation, and that, as I see it, is the main problem with trying to govern Internet standards. However, that being said, if the IETF standard is better than the Cisco technology (or Juniper or Brocade or Hitachi or whoever), then the IETF standard will win out in the long run (see OSPF vs EIGRP), because consumers ultimately want the best, most widely adopted technology, not necessarily the first technology. So then we're back to having a strong, impartial leadership at the IETF, rather than two or three companies jockeying to have their technology enthroned as a standard.

Roquefort and roll, baby.

Don't cross the streams it would be bad.

I think you mean Jon Steward

The question is simply answered: diagnoses are more prevalent because the drugs to treat those patients now exists. It is not mere coincidence that the FDA approved the use of Risperdal in late 2006, and its generic, Risperidone, in late 2008. There were more than a few doctors who have made more than a few dollars from prescribing tis medication. Johnson & Johnson has to pay a $2.2 billion dollar fine for illegally marketing this drug through the use of kickbacks to doctors and pharmacists. So don't tell me the pharmaceutical isn't dirtier than a whore's whose-its. Everyone relax. Autism rates will decline when these drugs get a bad enough name. Then, a more expensive drug will be produced to treat a more common malady, and everyone will freak the fuck out again.

These are Ice Age fossils... trust me, when they lived there, LA was very cool.

The trend towards de-anonymizing the Web (and other mobile communications), frankly, sucks. I don't want to sign into Facebook to comment on a Detroit Red Wings news article. I don't want to sign into Google+ to comment on a youtube video (only to have them tell me my name isn't real). I imagine and fear the day when our global unicast IPv6 address is tied to our DNA or some other biometric. Governments don't want us to be anonymous, to communicate without knowing who it is that's sending and who is receiving.

Randall's conception of robots is cute, but there's nothing cute about drones and ballistic missiles. We would be arguing over the definition of robot as we were being wiped out with automated weapons.